Tag: ASX:MXC
December 3, 2019
MGC Pharmaceuticals Receives Approval for Distribution in Ireland
MGC Pharmaceuticals has received formal approval from the Health Products Regulatory Authority (HPRA) in Ireland for the sale of CannEpil. November 27, 2019
MGC Pharma Sees Growth in Prescriptions for November
MGC Pharmaceuticals announced it has seen 40 percent growth since the end of October 2019 in the number of prescribed...
November 19, 2019
A Guide to Investing in Malta’s Medical Cannabis Market
INN takes a look at Malta medical cannabis market and the role it could play within the European and international... November 13, 2019
MGC Pharma Receives First Government Grant for Clinical Trial
MGC Pharma announced it's received government funding for its clinical trial with the University of Notre Dame Western Australia. November 5, 2019
MGC Pharma Posts Quarterly Update
MGC Pharmaceuticals shared with investors its financial report for its most recent quarter. October 31, 2019
MGC Pharmaceuticals Reports Update on LSE Listing
MGC Pharmaceuticals announced an increase in patient numbers and reported progress on its LSE listing in its September quarterly report. October 30, 2019